The significance of serum mitochondrial aspartate aminotransferase activity in obstructive jaundice: Experimental and clinical studies
The serum level of mitochondrial aspartate aminotransferase was determined in experimental and clinical obstructive jaundice, using an immunoabsorbance method which allowed the differential determination of cytosolic and mitochondrial isozymes in the serum. In experimental obstructive jaundice using dogs, the serum mitochondrial aspartate aminotransferase value rapidly decreased to normal after biliary decompression following a period of biliary obstruction of within 3 weeks. On the other hand, when the period of jaundice was prolonged for 5 weeks, the activity of the enzyme after biliary drainage still continued to show high values, being 14.2±1.8 Karmen units at 4 weeks following biliary decompression. Determination of aspartate aminotransferase activity in tissue from such organs as the liver, heart, kidney, skeletal muscle and brain, as well as serum samples with drawn from local veins, confirmed that high serum values of the enzyme in experimental obstructive jaundice were mostly attributable to hepatic impairment induced by biliary obstruction not by secondarily damaged tissues of other organs. Mitochondrial aspartate aminotransferase proved to be a more useful marker than other routine tests in icteric dogs. In 13 clinical patients with obstructive jaundice, decreasing rates of serum mitochondrial aspartate aminotransferase on the 7th and 14th postoperative days could be applied to evaluate the viability of the icteric liver. The decreasing rates were more advantageous than the preoperative activity itself in predicting the postoperative function of the liver. Thus, mitochondrial aspartate aminotransferase appears to serve as a useful marker for assessing the liver function in obstructive jaundice.
Key Wordsbiliary decompression liver function test mitochondrial aspartate aminotransferase
Unable to display preview. Download preview PDF.
- 2.Ozawa K, Yamaoka Y, Kitamura O, Nambu H, Kamiyama Y, Takeda H, Takasan H, Honjo I. Clinical application of cytochrome a (+a3) assay of mitochondria from liver specimens: An aid in determining metabolic tolerance of liver remnant for hepatic resection. Ann Surg 1974; 180: 868–876.PubMedCrossRefGoogle Scholar
- 4.Boyde TRC, Latner AL. Starch-gel electrophoresis of transaminases in human tissue extracts and sera. Biochem J 1962; 82: 51.Google Scholar
- 5.Awapara J, Seale B. Distribution of transaminases in rat organs. J Biol Chem 1952; 194: 492–502.Google Scholar
- 6.Björkerud S, Björntorp P, Scherstén J. Lysosomal enzyme activity in human liver in relation to the age of the patient and in cases with obstructive jaundice. Scand J Clin Lab Invest 1967; 20: 224–230.Google Scholar
- 12.Kodama M, Tanaka T, Kodama O, Harada M, Takeuchi H, Itoh N. Indications and problems for gastroenterological surgery in patients with hepatic dysfunction-special reference to the evaluation of routine liver function tests. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 1982 15: 680–695. (in Japanese)Google Scholar
- 13.Tashiro S, Ogata K, Yamasaki K, Hayashida N, Sada E, Murata E, Hiraoka T. Surgery in patients with hepatic dysfunction. Nippon shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 1982; 15: 686–692. (in Japanese)Google Scholar
- 17.Malloy HT, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem 1937; 119: 481–490.Google Scholar
- 19.Person DA, Judge RD. Effect of operation on serum transaminase levels. Arch Surg 1958; 77: 892–897.Google Scholar
- 24.Sato N, Koyama M, Hayashi N, Shichiri M, Kamada T, Abe H. A relationship between serum m-GOT and liver respiratory activity. Kanzo (Acta Hepatologica Japonica) 1982; 23: 361–363. (in Japanese with English Abst.)Google Scholar